<Disease><Name>ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY</Name><Synonym>17-ALPHA-HYDROXYLASE DEFICIENCY (CYP17); 17,20-LYASE DEFICIENCY, ISOLATED, INCLUDED</Synonym><OMIM><Number>202110</Number><URL>http://omim.org/entry/202110</URL></OMIM><Orphanet><Number>90793</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=90793</URL></Orphanet><Protein><Number>Steroid 17-alpha-hydroxylase/17,20 lyase</Number><URL>http://www.uniprot.org/uniprot/P05093</URL></Protein><ExPASy><Number>1.14.99.9</Number><URL>http://enzyme.expasy.org/EC/1.14.99.9</URL></ExPASy><Gene>10q24.32</Gene><ICD>E25.08</ICD><Summary>rare (1:50000, &gt;120 cases) ;autosomal recessive ; variants in the ;CYP17A1; gene;Combined 17-alpha-Hydroxylase/17,20-Lyase Deficiency - Isolated 17,20-Lyase Deficiency (very rare) females show hypogonadism, males show ambigous genitalia</Summary><Symptoms><symtomp><id>2384</id><symptom>adrenal hyperplasia</symptom><category>ENDOCRINE SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2113</id><symptom>amenorrhea</symptom><category>ENDOCRINE SYSTEM | GENITOURINARY TRACT</category></symtomp><symtomp><id>2221</id><symptom>cryptorchism</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3916</id><symptom>episodic course (clinical symptoms)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2319</id><symptom>genitalia, ambigous</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2377</id><symptom>gynecomastia</symptom><category>BODY | ENDOCRINE SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>2296</id><symptom>hypertension</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3502</id><symptom>hypokalemia / hypokalaemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3496</id><symptom>hypokalemic hypertension</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2066</id><symptom>metabolic alkalosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2127</id><symptom>osteoporosis</symptom><category>SKELATAL DEFECT</category></symtomp><symtomp><id>2406</id><symptom>puberty, delayed or missing</symptom><category>ENDOCRINE SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>2138</id><name>Sodium</name><specimen>urine</specimen><value /><min>40.00</min><max>220.00</max><unit>mmol/24h</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>2139</id><name>Potassium</name><specimen>urine</specimen><value /><min>3.00</min><max>125.00</max><unit>mmol/24h</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>446</id><name>17-Hydroxyprogesterone</name><specimen>plasma</specimen><value>decreased</value><min>1.00</min><max>93.00</max><unit>ng/dl</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>751</id><name>17-Hydroxyprogesterone</name><specimen>plasma</specimen><value>decreased</value><min>50.00</min><max>1800.00</max><unit>&#181;g/dl</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>473</id><name>Adrenocorticotropic hormone (ACTH)</name><specimen>plasma</specimen><value>increased</value><min>10.00</min><max>20.00</max><unit>pg/ml</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1195</id><name>Adrenocorticotropic hormone (ACTH)</name><specimen>plasma</specimen><value>increased</value><min>4.40</min><max>22.20</max><unit>pmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>798</id><name>Aldosterone</name><specimen>plasma</specimen><value>increased</value><min>5.00</min><max>60.00</max><unit>ng/dl</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>799</id><name>Aldosterone</name><specimen>plasma</specimen><value>increased</value><min>1.00</min><max>160.00</max><unit>ng/dl</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>310</id><name>Cortisol</name><specimen>serum</specimen><value>increased</value><min>28.00</min><max>662.00</max><unit>nmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>752</id><name>Cortisol</name><specimen>serum</specimen><value>increased</value><min>20.00</min><max>680.00</max><unit>nmol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>311</id><name>Cortisol</name><specimen>serum</specimen><value>increased</value><min>138.00</min><max>635.00</max><unit>nmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>293</id><name>Cortisol</name><specimen>serum</specimen><value>increased</value><min>82.00</min><max>413.00</max><unit>nmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>410</id><name>Potassium</name><specimen>serum</specimen><value>increased</value><min>3.90</min><max>5.90</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>411</id><name>Potassium</name><specimen>serum</specimen><value>increased</value><min>3.50</min><max>5.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>412</id><name>Potassium</name><specimen>serum</specimen><value>increased</value><min>3.50</min><max>5.50</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>801</id><name>Progesterone</name><specimen>serum</specimen><value>increased</value><min>0.00</min><max>0.30</max><unit>ng/ml</unit><age>child</age><method /><comment /></metabolite><metabolite><id>800</id><name>Progesterone</name><specimen>plasma</specimen><value>increased</value><min>0.11</min><max>0.26</max><unit>ng/ml</unit><age>child</age><method /><comment /></metabolite><metabolite><id>409</id><name>Sodium</name><specimen>serum</specimen><value>increased</value><min>134.00</min><max>146.00</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>413</id><name>Sodium</name><specimen>serum</specimen><value>increased</value><min>135.00</min><max>145.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>728</id><name>Sodium</name><specimen>sweat</specimen><value>increased</value><min>20.00</min><max>30.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1105</id><name>Sodium</name><specimen>serum</specimen><value>increased</value><min>135.00</min><max>145.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1100</id><name>Tetrahydro-11-deoxycorticosterone</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1101</id><name>Tetrahydro-11-deoxycortisol</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7352</id><title>Selective LC-MRM/SIM-MS based profiling of adrenal steroids reveals metabolic signatures of 17&#945;-hydroxylase deficiency</title><author>Lee C,</author><journal>J Steroid Biochem Mol Biol</journal><year>2020</year><book /><volume>198</volume><number>0</number><pages>105612</pages><co_aut>et al.</co_aut></literature><literature><id>7353</id><title>A report of congenital adrenal hyperplasia due to 17&#945;-hydroxylase deficiency in two 46,XX sisters</title><author>Espinosa-Herrera F,</author><journal>Gynecol Endocrinol. 2020 Jan;36(1):24-29. doi:</journal><year>2020</year><book /><volume>36</volume><number>1</number><pages>24-29</pages><co_aut>et al.</co_aut></literature><literature><id>7354</id><title>Partial deficiency of 17&#945;-hydroxylase: a rare cause of congenital adrenal hyperplasia</title><author>Sousa Paredes SC,</author><journal>BMJ Case Rep</journal><year>2019</year><book /><volume>12</volume><number>12</number><pages>e230778</pages><co_aut>et al.</co_aut></literature><literature><id>7355</id><title>A Novel Compound Heterozygous CYP17A1 Variant Causes 17&#945;-Hydroxylase/17, 20-Lyase Deficiency</title><author>Chen H,</author><journal>Front Genet</journal><year>2019</year><book /><volume>10</volume><number>996</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7356</id><title>Three new Brazilian cases of 17&#945;-hydroxylase deficiency: clinical, molecular, hormonal, and treatment features</title><author>Breder ISS,</author><journal>J Pediatr Endocrinol Metab</journal><year>2018</year><book /><volume>31</volume><number>8</number><pages>937-942</pages><co_aut>et al.</co_aut></literature><literature><id>4749</id><title>Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic</title><author>Auchus RJ</author><journal>J Steroid Biochem Mol Biol</journal><year>2017</year><book /><volume>165</volume><number>0</number><pages>71-78</pages><co_aut /></literature><literature><id>3253</id><title>A case of 17 alpha-hydroxylase deficiency</title><author>Kim SM,</author><journal>Clin Exp Reprod Med</journal><year>2015</year><book /><volume>42</volume><number>2</number><pages>72-76</pages><co_aut>Rhee JH</co_aut></literature><literature><id>3254</id><title>Etiological evaluation of adolescents with primary amenorrhea</title><author>Eren E,</author><journal>Indian J Pediatr</journal><year>2014</year><book /><volume>81</volume><number>9</number><pages>861-865</pages><co_aut>et al.</co_aut></literature><literature><id>4750</id><title>A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17,20-lyase deficiency, a case series of s</title><author>Kim YM,</author><journal>Metabolism</journal><year>2014</year><book /><volume>63</volume><number>1</number><pages>42-49</pages><co_aut>et al.</co_aut></literature><literature><id>3255</id><title>Primary amenorrhoea with hypertension: undiagnosed 17-+&#166;-hydroxylase deficiency</title><author>Britten FL,</author><journal>Med J Aust</journal><year>2013</year><book /><volume>199</volume><number>8</number><pages>556-558</pages><co_aut>Primary amenorrhoea with hypertension: undiagnosed 17-+&#166;-hydroxylase deficiency.</co_aut></literature><literature><id>3052</id><title>[Diagnosis and treatment of 17 alpha-hydroxylase deficiency: a case report and literature review]</title><author>Zhang L,</author><journal>Beijing Da Xue Xue Bao</journal><year>2008</year><book /><volume>40</volume><number>2</number><pages>221-222</pages><co_aut>Wang H, Hong T</co_aut></literature><literature><id>2681</id><title>Two Novel Mutations Found in a Patient with 17 {alpha}-Hydroxylase Enzyme Deficiency</title><author>Ergun-Longmire B</author><journal>J Clin Endocrinol Metab</journal><year>2006</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2193</id><title>17alpha-hydroxylase/17,20-Lyase deficiency due to novel compound heterozygote mutations: treatment for tall stature in a female</title><author>Schwab KO</author><journal>J Pediatr Endocrinol Metab</journal><year>2005</year><book /><volume>18</volume><number>4</number><pages>403-411</pages><co_aut>et al.</co_aut></literature><literature><id>1337</id><title>Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency</title><author>Costa-Santos M</author><journal>J Clin Endocrinol Metab</journal><year>2004</year><book /><volume>89</volume><number>1</number><pages>49-60</pages><co_aut>et al.</co_aut></literature><literature><id>1549</id><title>P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping</title><author>Martin RM</author><journal>J Clin Endocrinol Metab</journal><year>2003</year><book /><volume>88</volume><number>12</number><pages>5739-5746</pages><co_aut>et al.</co_aut></literature><literature><id>126</id><title>Congenital adrenal hyperplasia</title><author>Donohoue P</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2929-2966</pages><co_aut>et al.</co_aut></literature><literature><id>309</id><title>17-Hydroxylase/17,20-desmolase deficiency: from clinical investigation to molecular definition</title><author>Yanase T</author><journal>Endocr Rev</journal><year>1991</year><book /><volume>12</volume><number>0</number><pages>91</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>